[1] Ge Q, Tian Q, Tseng H, et al. Development of low-dose reproductive hormone therapies in China[J]. Gynecol Endocrinol, 2006, 22(11):636-645. [2] Perlikowska R, Janecka A. Bioavailability of endomorphins and the blood-brain barrier--a review[J]. Med Chem, 2014,10(1):2-17. [3] Hung K C, Wu H E, Mizoguchi H, et al. Intrathecal treatment with 6-hydroxydopamine or 5, 7-dihydroxytryptamine blocks the antinociception induced by endomorphin-1 and endomorphin-2 given intracerebroventricularly in the mouse[J]. J Pharmacol Sci, 2003, 93(3):299-306. [4] Hiller, J M, Itzhak, Y, Simon, E J. Selective changes in mu, delta and kappa opioid receptor binding in certain limbic regions of the brain in Alzheimer’s disease patients[J]. Brain Res, 1987, 406(1-2):17-23. [5] Fichna J, Janecka A, Costentin J, et al. The endomorphin system and its evolving neurophysiological role[J]. Pharmacol Rev, 2007, 59(1):88-123. [6] Micevych P E, Wong A M, Mittelman-Smith MA. Estradiol Membrane-Initiated Signaling and Female Reproduction[J]. Compr Physiol,2015,5(3):1211-1222. [7] Sinchak K, Micevych P E. Progesterone blockade of estrogen activation of mu-opioid receptors regulates reproductive behavior[J]. J Neurosci, 2001, 21(15):5723-5729. [8] Ukai M, Lin H P. Involvement of mu(1)-opioid receptors and cholinergic neurotransmission in the endomorphins-induced impairmentof passive avoidance learning in mice[J]. Behav Brain Res, 2002,129(1-2):197-201. [9] Ukai M, Watanabe Y, Kameyama T. Effects of endomorphins-1 and -2, endogenous mu-opioid receptor agonists, on spontaneous alternation performance in mice[J]. Eur J Pharmacol, 2000, 395(3):211-215. [10] Ukai M, Lin H P. Endomorphins 1 and 2 induce amnesia via selective modulation of dopamine receptors in mice[J]. Eur J Pharmacol, 2002, 446(1-3):97-101. [11] Spence R D, Wisdom A J, Cao Y, et al. Estrogen mediates neuroprotection and anti-inflammatory effects during EAE through ERα signaling on astrocytes but not through ERβ signaling on astrocytes or neurons[J]. J Neurosci, 2013, 33(26):10924-10933. [12] Wang C, Jie C, Dai X. Possible roles of astrocytes in estrogen neuroprotection during cerebral ischemia[J]. Rev Neurosci,2014,25(2):255-268. [13] Maki P M, Dennerstein L, Clark M, et al. Perimenopausal use of hormone therapy is associated with enhanced memory and hippocampal function later in life[J]. Brain Res, 2011,1379:232-243. [14] Yoon B K, Kim D K, Kang Y, et al. Hormone replacement therapy in postmenopausal women with Alzheimer’s disease: a randomized, prospective study[J]. Fertil Steril, 2003, 79(2):274-280. [15] Shaywitz S E, naftolin F, Zelterman D, et al. Better oral reading and short term memory in midlife, postmenopausal women taking estrogen[J]. Menopause, 2003,10(5):420-426. [16] Yue Y, Hu L, Tian Q J, et al. Effects of long-term, low dose sex hormone replacement therapy on hippocampus and cognition of postmenopausal women of different apoE genotypes[J]. Acta Pharmacol Sin, 2007, 28(8):1129-1135. |